Skip to main content
. 2021 Nov 9;2021(11):CD013290. doi: 10.1002/14651858.CD013290.pub2

Wen 2015.

Study characteristics
Methods Randomized controlled trial
Participants
  • NSAID

    • n = 20, age 45.5 ± 9.1

    • Type of breast surgery reconstruction mastectomy

    • Breast cancer history

  • Fentanyl alone

    • n = 20, age 43.9 ± 7.8

    • Type of breast surgery reconstruction: mastectomy

    • Breast cancer history

Interventions
  • NSAID versus other analgesic

    • Flurbiprofen 3 mg/kg IV infusion 48 hours postoperative

Outcomes
  • Postoperative pain intensity within 24 (± 12) hours of surgery: VAS 2.6 ± 0.66 versus 2.55 ± 0.66

  • Incidence rate or severity of PONV: 2 versus 12 participants

  • Opioid use within 24 (± 12) hours of surgery 26.8 ± 1.8 mg versus 80.7 ± 4.8 mg morphine

Notes No declaration of funding or conflicts of interest
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Randomized controlled trial
Allocation concealment (selection bias) Low risk Secure web‐based computer‐generated randomisation process that automatically records numbers and assignments. A researcher who
did not participate in the clinical trial performed the process of randomising patients.
Blinding of participants and personnel (performance bias)
All outcomes Low risk Double‐blinded study
Blinding of outcome assessment (detection bias)
All outcomes Low risk Double‐blinded study
Incomplete outcome data (attrition bias)
All outcomes Low risk All patients completed the study
Selective reporting (reporting bias) High risk No information available for trial registrations or protocols to determine if all reported outcomes were assessed

IM: intramuscular
IV: intravenous
NaCl: sodium chloride
NRS: numerical rating scale
NSAID: nonsteroidal anti‐inflammatory drug
PONV: postoperative nausea and vomiting
VAS: visual analog scale